Skip to main content
SpringerLink
Log in

Somatic Mutations Associated with Metastasis in Acral Melanoma

  • MOLECULAR CELL BIOLOGY
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Acral melanoma is one of the most aggressive and fast-growing forms of cutaneous melanoma and is characterized by a predominant location on the palms and feet. Primary tumors, metastases, and normal tissue samples from five acral melanoma patients were examined by massive parallel sequencing, focusing on the coding regions of 4100 genes involved in the origin and progression of hereditary and oncology diseases. Somatic mutations were found in genes related to cell division, proliferation, and apoptosis (BRAF, NRAS, VAV1, GATA1, and GCM2); cell adhesion (CTNND2 and ITGB4); angiogenesis (VEGFA); and the regulation of energy metabolism (BCS1L). Comparisons of target DNA sequences between morphologically normal and primary tumor tissues and between normal and metastatic tissues identified the candidate genes responsible for rapid metastasis in acral melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. Grebennikova O.P., Prilepo V.N. 2009. Melanoma, in Onkologiya dlya praktikuyushchikh vrachei (Oncology for Practicing Physicians), Chistyakov S.S., Ed., Moscow: KMK, pp. 548–563.

  2. Bertolotto C. 2013. Melanoma: From melanocyte to genetic alterations and clinical options. Scientifica (Cairo). 2013, 1–22.

    Article  CAS  Google Scholar 

  3. Mazurenko N.N. 2014. Genetic features and markers of skin melanoma. Usp. Mol. Onkol. 2, 26–35.

    Google Scholar 

  4. Feibleman C.E., Stoll H., Maize J.C. 1980. Melanomas of the palm, sole, and nailbed: A clinicopathologic study. Cancer. 46 (11), 2492–2504.

    Article  CAS  PubMed  Google Scholar 

  5. Borisova T.N., Kudryavtseva G.T. 2005. Combined treatment of metastatic acral melanoma. Sib. Oncol. Zh. 7 (14), 39–41.

    Google Scholar 

  6. Curtin J.A., Fridlyand J., Kageshita T., Patel H.N., Busam K.J., Kutzner H., Cho K.H., Aiba S., Bröcker E.B., LeBoit P.E., Pinkel D., Bastian B.C. 2005. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353 (20), 2135–2147.

    Article  CAS  PubMed  Google Scholar 

  7. Bolger A.M., Lohse M., Usadel B. 2014. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 30 (15), 2114–2120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., DePristo M.A. 2010. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20 (9), 1297–1303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cibulskis K., Lawrence M.S., Carter S.L., Sivachenko A., Jaffe D., Sougnez C., Gabriel S., Meyerson M., Lander E.S., Getz G. 2013. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31 (3), 213–219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Vaser R., Adusumalli S., Leng S.N., Sikic M., Ng P.C. 2016. SIFT missense predictions for genomes. Nat. Protoc. 11 (1), 1–9.

    Article  CAS  PubMed  Google Scholar 

  11. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. 2010. A method and server for predicting damaging missense mutations. Nat. Methods. 7 (4), 248–249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Schwarz J.M., Cooper D.N., Schuelke M., Seelow D. 2014. MutationTaster2: Mutation prediction for the deep-sequencing age. Nat. Methods. 11 (4), 361–362.

    Article  CAS  PubMed  Google Scholar 

  13. Chun S., Fay J.C. 2009. Identification of deleterious mutations within three human genomes. Genome Res. 19 (9), 1553–1561.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhu X., Jin H., Xia Z., Wu X., Yang M., Zhang H., Shang X., Cheng R., Zhan Z., Yu Z. 2017. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis. Biochem. Biophys. Res. Commun. 486 (2), 571–576.

    Article  CAS  PubMed  Google Scholar 

  15. Ling T., Crispino J.D., Zingariello M., Martelli F., Migliaccio A.R. 2018. GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy. Expert Rev. Hematol. 11 (3), 169–184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bot S.T., Vermeer S., Buijsman W., Heister A., Voorendt M., Verrips A., Scheffer H., Kremer H.P., Warrenburg B.P., Kamsteeg E.J. 2013. Pure adult-onset spastic paraplegia caused by a novel mutation in the KIAA0196 (SPG8) gene. J. Neurol. 260 (7), 1765–1769.

    Article  CAS  PubMed  Google Scholar 

  17. Bierie B., Pierce S.E., Kroeger C., Stover D.G., Pattabiraman D.R., Thiru P., Liu Donaher J., Reinhardt F., Chaffer C.L., Keckesova Z., Weinberg R.A. 2017. Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 114 (12), E2337–E2346.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tahara H., Naito H., Kise K., Wakabayashi T., Kamoi K., Okihara K., Yanagisawa A., Nakai Y., Nonomura N., Morii E., Miki T., Takakura N. 2015. Evaluation of PSF1 as a prognostic biomarker for prostate cancer. Prostate Cancer Prostatic Dis. 18 (1), 56–62.

    Article  CAS  PubMed  Google Scholar 

  19. Zhang J., Wu Q., Wang Z., Zhang Y., Zhang G., Fu J., Liu C. 2015. Knockdown of PSF1 expression inhibits cell proliferation in lung cancer cells in vitro. Tumor Biol. 36 (3), 2163–2168.

    Article  CAS  Google Scholar 

  20. Temprano A., Sembongi H., Han G.S., Sebastián D., Capellades J., Moreno C., Guardiola J., Wabitsch M., Richart C., Yanes O., Zorzano A., Carman G.M., Siniossoglou S., Miranda M. 2016. Redundant roles of the phosphatidate phosphatase family in triacylglycerol synthesis in human adipocytes. Diabetologia. 59 (9), 1985–1994.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Beeler N., Riederer B.M., Waeber G., Abderrahmani A. 2009. Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes. Brain Res. Bull. 80 (4–5), 274–281.

    Article  CAS  PubMed  Google Scholar 

  22. Sun Y., Wang F., Sun X., Wang X., Zhang L., Li Y. 2017. CX3CR1 regulates osteoarthrosis chondrocyte proliferation and apoptosis via Wnt/β-catenin signaling. Biomed. Pharmacother. 96, 1317–1323.

    Article  CAS  PubMed  Google Scholar 

  23. Wang H., Cai J., Du S., Guo Z., Xin B., Wang J., Wei W., Shen X. 2017. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells. Cell Biochem. Funct. 35 (6), 315–326.

    Article  CAS  PubMed  Google Scholar 

  24. Stout M.C., Narayan S., Pillet E.S., Salvino J.M., Campbell P.M. 2018. Inhibition of CX3CR1 reduces cell motility and viability in pancreatic adenocarcinoma epithelial cells. Biochem. Biophys. Res. Commun. 495 (3), 2264–2269.

    Article  CAS  PubMed  Google Scholar 

  25. Everything about cancer: diagnosis, therapy, oncologists’ advice online, OncoForum. http://www.oncoforum.ru/. Accessed November 17, 2018.

Download references

Funding

This work was supported by the Russian Science Foundation (project no. 14-35-00107).

Author information

Authors and Affiliations

  1. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia

    I. S. Abramov, M. A. Emelyanova, G. S. Krasnov, A. S. Zasedatelev & T. V. Nasedkina

  2. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 115478, Moscow, Russia

    O. O. Ryabaya

Authors
  1. I. S. Abramov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. Emelyanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. O. Ryabaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. S. Krasnov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. S. Zasedatelev
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. V. Nasedkina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. V. Nasedkina.

Ethics declarations

Conflict of interests. The authors declare that they have no conflict of interest.

Statement of compliance with standards of research involving humans as subjects. The study was approved by the Ethics Committee at the Blokhin National Medical Research Center of Oncology (Ministry of Health of the Russian Federation). All patients gave their written informed consent to their tissue samples being used for research purposes.

Additional information

Translated by T. Tkacheva

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abramov, I.S., Emelyanova, M.A., Ryabaya, O.O. et al. Somatic Mutations Associated with Metastasis in Acral Melanoma. Mol Biol 53, 580–585 (2019). https://doi.org/10.1134/S0026893319040022

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893319040022

Keywords:

Search

Navigation